Pharmaceutical News Headlines for May 23 2012 ( Wednesday )


• Veloxis Pharmaceuticals A/S (VELO) to Cut Almost Half of Staff More...

• Merck & Co., Inc. (MRK) CEO: Singulair, Economy to Make 2012-13 Tough But We Will Survive More...

• Seahorse Bioscience Raises $9.4 Million for Biotech Labware More...

• Bridgepoint Plans to Sell Drugs Maker Aenova for About $510 Million More...

• APP Pharmaceuticals Acquires Three Products from Nexus More...

• Hisun Pharma, Pfizer Inc. (PFE) to Set Up $250 Million JV More...

• RayBiotech Establishes Master Services Agreement With Major Biopharmaceutical Company More...

• IntelliCell BioSciences (SVFC) Announces Collaborative Agreement with the University of Florida on Stem Cell and Tissue Repair Research More...

• Immune Pharmaceuticals Announces Strategic Partnership With the World-Renowned Weizmann Institute More...

• Alnylam Pharmaceuticals (ALNY) and PBL Sign License Agreement forBaulcombe & Hamilton RNAi Patent More...

• PPD, Inc. (PPDI) Names David Simmons Chairman and CEO More...

• Jim DuCharme Joins Prime Therapeutics as Chief Financial Officer More...

• Pfizer Inc. (PFE) Names Olivier Brandicourt as President and General Manager, Emerging Markets and Established Products Business Units More...

• Carbohydrate Expert Joins RSSL More...

• Mesa Labs (MLAB) Reports 28% Increase in Annual Net Income More...

• FDA: Authorities Seize Unapproved Crescendo Therapeutics Drug More...

• Neurosearch A/S (NEUR.CO) Accused of Manipulating Stock Prices More...

• FDA: Feds Seize Crescendo Therapeutics' Unapproved Scar Drug More...

• Prodigy Generics and eVenus Announce the Launch of Oncology Injectable Irinotecan More...

• Allergy Therapeutics plc: Notification of Voluntary Product Recall of Anapen® by Lincoln Medical More...

• Novo Nordisk A/S (NVO) Diabetes Drug Gets FDA Nod for Toddlers More...

• Perrigo Company (PRGO) Receives FDA Approval for Butoconazole Nitrate 2% Vaginal Cream More...

• FDA Delays Abbott Laboratories (ABT)'s New Use for Top Drug Humira More...

• Furiex Pharmaceuticals, Inc. (FURX) Confirms Takeda Pharmaceutical Co. Ltd. (TKDG.DE)'s Announcement on the Acceptance of the European Medicines Agency Submission of Alogliptin for the Treatment of Type 2 Diabetes More...

• Seattle Genetics, Inc. (SGEN) Announces Health Canada Accepts ADCETRIS├é® New Drug Submission for Review More...

• Zytoprotec Completes Phase I/II Trial of Novel Dialysate, Enters into Negotiations With Global Pharmaceutical Company More...

• Do Bald Men Face Higher Risk of Prostate Cancer? University of Toronto Study More...

• Asthma Meds May be Linked to Irregular Heartbeat, University of Illinois Study More...

• Disagreeable People Prefer Aggressive Dogs, University of Leicester Study More...

• Senesco Technologies, Inc. (SNT)'s SNS01 is a Potent Regulator of Programmed Cell Death and Tumor Growth in Murine Models of Multiple Myeloma More...

• New Data Support Role of Prometheus Laboratories Inc.' Novel Assay in Optimizing IBD Treatment Management More...

• Avaxia Biologics, Inc. is Awarded U.S. Patent for Method to Treat Radiation Damage to the Digestive Tract and Mucositis Caused by Radiation More...

• MicuRx Pharmaceuticals Announces Issuance of U.S. Patent for Its Next-Generation Antibacterial Agent More...
Tags: , ,

About author

Make it happen !!

0 comments

Leave a Reply